Important update: Healthcare facilities
CDC has updated select ways to operate healthcare systems effectively in response to COVID-19 vaccination.
Learn more
Find the latest information:
Recommendations for Fully Vaccinated People
COVID-19 Homepage
Recommendations for Fully Vaccinated People
COVID-19 Homepage
UPDATE
Given new evidence on the B.1.617.2 (Delta) variant, CDC has updated the guidance for fully vaccinated people. CDC recommends universal indoor masking for all teachers, staff, students, and visitors to K-12 schools, regardless of vaccination status. Children should return to full-time in-person learning in the fall with layered prevention strategies in place.
UPDATE
The White House announced that vaccines will be required for international travelers coming into the United States, with an effective date of November 8, 2021. For purposes of entry into the United States, vaccines accepted will include FDA approved or authorized and WHO Emergency Use Listing vaccines. More information is available here.
Clinical Course: Progression, Management, and Treatment
Clinical Course: Progression, Management, and Treatment
Clinical considerations for care of children and adults with confirmed COVID-19
The content of this page is being updated to reflect FDA's emergency use authorization for Pemgarda (pemivibart), a monoclonal antibody for pre-exposure prevention of COVID-19 in people ages 12 years and older who are moderately to severely immunocompromised. Pemgarda is not a substitute for COVID-19 vaccination and provides additional protection even among people who have received the vaccine. Learn more.
PAGE 4 of 5
‹ View Table of Contents
What You Need to Know
- The clinical spectrum of SARS-CoV-2 infection includes asymptomatic infection and mild, moderate, severe, and critical illness.
- Information about clinical management and treatment of COVID-19 is categorized by severity of illness.
- Most patients with mild or moderate COVID-19 can be managed in an outpatient setting.
- Most patients with severe or critical COVID-19 illness require hospitalization.
Mild to Moderate Illness
Most patients with COVID-19 experience asymptomatic SARS-CoV-2, or mild to moderate illness that can be managed in the outpatient setting.
Severe to Critical Illness
More Information
- COVID-19 Test to Treat Locators
- NIH Treatment Guidelines for Non-hospitalized Adults
- Therapeutic Management of Hospitalized Adults With COVID-19
- Paxlovid™ Drug-Drug Interactions
- COVID-19 Therapeutics Decision Aid
- Side-by-Side Overview of Therapeutics
- Outpatient COVID-19 Therapeutics Administration Guide for Healthcare Providers
- Key Points
- Clinical Presentation
- › Clinical Progression, Management, and Treatment
- Special Clinical Considerations
References
email_03Get Email Updates
To receive email updates about COVID-19, enter your email address: